We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601066:SSECSC Financial Co., Ltd. Class A Analysis

Data as of 2026-05-28 - not real-time

CN¥23.10

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

CSC Financial is trading at CNY 23.1, comfortably above its 20‑day SMA (22.71) and 50‑day SMA (22.20) while still below the 200‑day SMA (24.87), indicating short‑term bullish momentum but long‑term headroom. MACD is in bullish territory (line 0.236 > signal 0.145) and volume is increasing, supporting the technical upside. The DCF‑derived fair value of roughly CNY 312 suggests a massive valuation gap, classifying the stock as undervalued on a fundamental basis. Revenue has surged 61% year‑over‑year and margins remain healthy (gross 55%, operating 60%), providing a strong growth narrative. Dividend yield of 1.39% with a payout ratio under 25% points to a sustainable income stream. However, the balance sheet is heavily leveraged (debt‑to‑equity > 290%) and the 30‑day volatility of 27% adds price‑risk.
Given the low beta (~0.32) the stock is relatively insulated from broader market swings, yet regulatory and geographic exposure in China remain material concerns. The combination of bullish technical cues, deep valuation discount, and solid cash‑flow generation supports a cautious buying stance, while the debt load and sector risk temper enthusiasm for aggressive positioning.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD histogram
  • Price above short‑term SMAs
  • Increasing trading volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth but high leverage
  • Sustainable dividend yield
  • Regulatory environment in China

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Large DCF upside potential
  • Consistent profitability and margins
  • Long‑term market position in capital markets

Key Metrics & Analysis

Financial Health

Revenue Growth61.40%
Profit Margin43.50%
P/E Ratio17.4
ROE9.71%
ROA1.63%
Debt/Equity290.77
P/B Ratio2.1
Op. Cash FlowCN¥93.1B
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI55.9
SupportCN¥21.45
ResistanceCN¥24.11
MA 20CN¥22.71
MA 50CN¥22.20
MA 200CN¥24.87
MACDBullish
VolumeIncreasing
Fear & Greed Index93.38

Valuation

Fair ValueCN¥312.10
GradeUndervalued
TypeGrowth
Dividend Yield1.39%

Risk Assessment

Beta0.32
Volatility27.22%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.